Karo Pharma chooses mSix & Partners as EMEA media agency

Ella Sagar

•

March 29, 2022

•

1 minute

Karo Pharma has named GroupM and The&Partnership’s joint venture mSix & Partners as its EMEA media agency of record.

(Picture and logo supplied)

More from the author

Have brands changed their approach to South Asian Heritage Month?

Read more

Ella Sagar Ella Sagar is a reporter for The Media Leader and leads our audio and out-of-home coverage. She joined in September 2021 and has a gold standard NCTJ. She previously wrote for the South West Londoner, Ealing Times, and The Hillingdon Times. At the University of Leeds, she received a First Class Honours Degree in French and Spanish with distinction in speaking and during her time there regularly presented radio shows on Leeds Student Radio, wrote for the student paper The Gryphon and was editor of Her Campus Leeds.

Karo Pharma has named GroupM and The&Partnership’s joint venture mSix & Partners as its EMEA media agency of record.

mSix & Partners won the EMEA media planning and buying account for the consumer healthcare company after a competitive pitch involving multiple agency groups, with the transition starting immediately.

The partnership will be effective from 1 April and the agency’s pitch focused on strategic planning, executional capabilities, tools, technology, ROI measurement and competitive pricing.

Karo Pharma’s focus is on future growth, brand-building, central media management and local expertise.

The account is estimated to be worth €25m and comprises consumer healthcare brands like E45 (subject to the closing of a ‘put option agreement’), Multi-Gyn, Paracet, Nailner, CCS and Flux.